Cargando…

Resveratrol Pretreatment Improved Heart Recovery Ability of Hyperglycemic Bone Marrow Stem Cells Transplantation in Diabetic Myocardial Infarction by Down-Regulating MicroRNA-34a

AIM: To examine the effect of resveratrol (RSV) on bone marrow mesenchymal stem cells (BMSCs) under hyperglycemic conditions and on BMSCs transplantation in diabetic rats with myocardial infarction (MI). METHODS: In vitro, BMSCs were isolated from 3-week-old male Sprague Dawley (SD) rats and culture...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fengyun, Wang, Kun, Gao, Fei, Xuan, Yongli, Liu, Xiaohong, Zhang, Zhuoqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223511/
https://www.ncbi.nlm.nih.gov/pubmed/34177568
http://dx.doi.org/10.3389/fphar.2021.632375
_version_ 1783711709370777600
author Zhang, Fengyun
Wang, Kun
Gao, Fei
Xuan, Yongli
Liu, Xiaohong
Zhang, Zhuoqi
author_facet Zhang, Fengyun
Wang, Kun
Gao, Fei
Xuan, Yongli
Liu, Xiaohong
Zhang, Zhuoqi
author_sort Zhang, Fengyun
collection PubMed
description AIM: To examine the effect of resveratrol (RSV) on bone marrow mesenchymal stem cells (BMSCs) under hyperglycemic conditions and on BMSCs transplantation in diabetic rats with myocardial infarction (MI). METHODS: In vitro, BMSCs were isolated from 3-week-old male Sprague Dawley (SD) rats and cultured under hyperglycemic conditions for up to 28 days. Cell viability was analyzed by cell counting kit-8 (CCK-8) assays. The expression of miR-34a was measured by RT-qPCR. Western blotting was used to examine the protein expression of SIRT1, P21, P16, VEGF and HIF-1α. A senescence-associated β-galactosidase assay was used to examine the senescence level of each group. In vivo, a diabetes model was established by feeding rats a high-sugar and high-fat diet for 8 weeks, injecting the animals with streptozotocin (STZ) and continuing high-sugar and high-fat feeding for 4 additional weeks. Then, left anterior descending coronary artery (LAD) cessation was used to established the myocardial infarction (MI) models. Each group of rats was transplanted with differentially preconditioned BMSCs after myocardial infarction. Ultrasound was used to analyze cardiac function 1 and 3 weeks after the operation, and frozen heart sections were used for immunohistochemical analysis, Masson staining and CD31 measurement. In addition, ELISA analysis of serum cytokine levels was performed. RESULTS: This study showed that the viability of BMSCs cultured under hyperglycemic conditions was decreased, the cells became senescent. Besides, an obviously increased in the expression of miR-34a was detected. Moreover, RSV preconditioning reduced the expression of miR-34a in BMSCs after high glucose stimulation and rejuvenated BMSCs under hyperglycemic conditions. Further analysis showed that the transplantation of RSV-BMSCs were benefit to heart recovery following infarction in diabetic rats, promoted proangiogenic factor release and increased arteriole and capillary densities. CONCLUSION: RSV rejuvenated BMSCs after chronic hyperglycemia-induced senescence by interacting with miR-34a and optimized the therapeutic effect of BMSCs on diabetes with myocardial infarction.
format Online
Article
Text
id pubmed-8223511
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82235112021-06-25 Resveratrol Pretreatment Improved Heart Recovery Ability of Hyperglycemic Bone Marrow Stem Cells Transplantation in Diabetic Myocardial Infarction by Down-Regulating MicroRNA-34a Zhang, Fengyun Wang, Kun Gao, Fei Xuan, Yongli Liu, Xiaohong Zhang, Zhuoqi Front Pharmacol Pharmacology AIM: To examine the effect of resveratrol (RSV) on bone marrow mesenchymal stem cells (BMSCs) under hyperglycemic conditions and on BMSCs transplantation in diabetic rats with myocardial infarction (MI). METHODS: In vitro, BMSCs were isolated from 3-week-old male Sprague Dawley (SD) rats and cultured under hyperglycemic conditions for up to 28 days. Cell viability was analyzed by cell counting kit-8 (CCK-8) assays. The expression of miR-34a was measured by RT-qPCR. Western blotting was used to examine the protein expression of SIRT1, P21, P16, VEGF and HIF-1α. A senescence-associated β-galactosidase assay was used to examine the senescence level of each group. In vivo, a diabetes model was established by feeding rats a high-sugar and high-fat diet for 8 weeks, injecting the animals with streptozotocin (STZ) and continuing high-sugar and high-fat feeding for 4 additional weeks. Then, left anterior descending coronary artery (LAD) cessation was used to established the myocardial infarction (MI) models. Each group of rats was transplanted with differentially preconditioned BMSCs after myocardial infarction. Ultrasound was used to analyze cardiac function 1 and 3 weeks after the operation, and frozen heart sections were used for immunohistochemical analysis, Masson staining and CD31 measurement. In addition, ELISA analysis of serum cytokine levels was performed. RESULTS: This study showed that the viability of BMSCs cultured under hyperglycemic conditions was decreased, the cells became senescent. Besides, an obviously increased in the expression of miR-34a was detected. Moreover, RSV preconditioning reduced the expression of miR-34a in BMSCs after high glucose stimulation and rejuvenated BMSCs under hyperglycemic conditions. Further analysis showed that the transplantation of RSV-BMSCs were benefit to heart recovery following infarction in diabetic rats, promoted proangiogenic factor release and increased arteriole and capillary densities. CONCLUSION: RSV rejuvenated BMSCs after chronic hyperglycemia-induced senescence by interacting with miR-34a and optimized the therapeutic effect of BMSCs on diabetes with myocardial infarction. Frontiers Media S.A. 2021-04-20 /pmc/articles/PMC8223511/ /pubmed/34177568 http://dx.doi.org/10.3389/fphar.2021.632375 Text en Copyright © 2021 Zhang, Wang, Gao, Xuan, Liu and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zhang, Fengyun
Wang, Kun
Gao, Fei
Xuan, Yongli
Liu, Xiaohong
Zhang, Zhuoqi
Resveratrol Pretreatment Improved Heart Recovery Ability of Hyperglycemic Bone Marrow Stem Cells Transplantation in Diabetic Myocardial Infarction by Down-Regulating MicroRNA-34a
title Resveratrol Pretreatment Improved Heart Recovery Ability of Hyperglycemic Bone Marrow Stem Cells Transplantation in Diabetic Myocardial Infarction by Down-Regulating MicroRNA-34a
title_full Resveratrol Pretreatment Improved Heart Recovery Ability of Hyperglycemic Bone Marrow Stem Cells Transplantation in Diabetic Myocardial Infarction by Down-Regulating MicroRNA-34a
title_fullStr Resveratrol Pretreatment Improved Heart Recovery Ability of Hyperglycemic Bone Marrow Stem Cells Transplantation in Diabetic Myocardial Infarction by Down-Regulating MicroRNA-34a
title_full_unstemmed Resveratrol Pretreatment Improved Heart Recovery Ability of Hyperglycemic Bone Marrow Stem Cells Transplantation in Diabetic Myocardial Infarction by Down-Regulating MicroRNA-34a
title_short Resveratrol Pretreatment Improved Heart Recovery Ability of Hyperglycemic Bone Marrow Stem Cells Transplantation in Diabetic Myocardial Infarction by Down-Regulating MicroRNA-34a
title_sort resveratrol pretreatment improved heart recovery ability of hyperglycemic bone marrow stem cells transplantation in diabetic myocardial infarction by down-regulating microrna-34a
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223511/
https://www.ncbi.nlm.nih.gov/pubmed/34177568
http://dx.doi.org/10.3389/fphar.2021.632375
work_keys_str_mv AT zhangfengyun resveratrolpretreatmentimprovedheartrecoveryabilityofhyperglycemicbonemarrowstemcellstransplantationindiabeticmyocardialinfarctionbydownregulatingmicrorna34a
AT wangkun resveratrolpretreatmentimprovedheartrecoveryabilityofhyperglycemicbonemarrowstemcellstransplantationindiabeticmyocardialinfarctionbydownregulatingmicrorna34a
AT gaofei resveratrolpretreatmentimprovedheartrecoveryabilityofhyperglycemicbonemarrowstemcellstransplantationindiabeticmyocardialinfarctionbydownregulatingmicrorna34a
AT xuanyongli resveratrolpretreatmentimprovedheartrecoveryabilityofhyperglycemicbonemarrowstemcellstransplantationindiabeticmyocardialinfarctionbydownregulatingmicrorna34a
AT liuxiaohong resveratrolpretreatmentimprovedheartrecoveryabilityofhyperglycemicbonemarrowstemcellstransplantationindiabeticmyocardialinfarctionbydownregulatingmicrorna34a
AT zhangzhuoqi resveratrolpretreatmentimprovedheartrecoveryabilityofhyperglycemicbonemarrowstemcellstransplantationindiabeticmyocardialinfarctionbydownregulatingmicrorna34a